Texas 2009 81st Regular

Texas House Bill HB19 House Committee Report / Fiscal Note

Filed 02/01/2025

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD    Austin, Texas      FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION            March 24, 2009      TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health      FROM: John S. O'Brien, Director, Legislative Budget Board     IN RE:HB19 by Leibowitz (Relating to the labeling requirements for drugs dispensed by pharmacists.), Committee Report 1st House, Substituted    No significant fiscal implication to the State is anticipated.  The bill would amend the Occupations Code and would require the Texas State Board of Pharmacy to adopt rules relating to labeling requirements for drugs dispensed by pharmacists. Based on the information provided by the Texas State Board of Pharmacy, it is assumed that costs associated with implementing the provisions of the bill could be absorbed within existing resources. Local Government Impact No fiscal implication to units of local government is anticipated.    Source Agencies:515 Board of Pharmacy   LBB Staff:  JOB, CL, MW, ES, JRO    

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION
March 24, 2009





  TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health      FROM: John S. O'Brien, Director, Legislative Budget Board     IN RE:HB19 by Leibowitz (Relating to the labeling requirements for drugs dispensed by pharmacists.), Committee Report 1st House, Substituted  

TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
FROM: John S. O'Brien, Director, Legislative Budget Board
IN RE: HB19 by Leibowitz (Relating to the labeling requirements for drugs dispensed by pharmacists.), Committee Report 1st House, Substituted

 Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health 

 Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health 

 John S. O'Brien, Director, Legislative Budget Board

 John S. O'Brien, Director, Legislative Budget Board

HB19 by Leibowitz (Relating to the labeling requirements for drugs dispensed by pharmacists.), Committee Report 1st House, Substituted

HB19 by Leibowitz (Relating to the labeling requirements for drugs dispensed by pharmacists.), Committee Report 1st House, Substituted



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.



The bill would amend the Occupations Code and would require the Texas State Board of Pharmacy to adopt rules relating to labeling requirements for drugs dispensed by pharmacists. Based on the information provided by the Texas State Board of Pharmacy, it is assumed that costs associated with implementing the provisions of the bill could be absorbed within existing resources.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies: 515 Board of Pharmacy

515 Board of Pharmacy

LBB Staff: JOB, CL, MW, ES, JRO

 JOB, CL, MW, ES, JRO